Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12948-015-0025-9 http://scihub22266oqcxt.onion/10.1186/s12948-015-0025-9 C4556310!4556310 !26330764     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26330764 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26330764 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Mol+Allergy 2015 ; 13 (1 ): 19 Nephropedia Template TP {{tp|p=26330764 |t=2015. Rituximab in refractory sarcoidosis: a single centre experience |pdf=|usr=}}{{26330764 }} gab.com Text Rituximab in refractory sarcoidosis: a single centre experience JO: Clin Mol Allergy http://www.kidney.de/pget.php?&tw=1&pmid=26330764 #FOAvip Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease is still a great challenge. Rituximab is an anti-CD20 chimeric monoclonal antibody, currently used for the treatment of B cell malignancies and systemic autoimmune diseases. There are few case reports describing the successful use of Rituximab in refractory sarcoidosis with lung, eye, lymph nodes and skin involvement. In this paper we described three different case reports in which Rituximab has been used to treat refractory sarcoidosis and we reviewed the existing literature. Twit Text FOAVip Rituximab in refractory sarcoidosis: a single centre experience ????Clin Mol Allergy http://www.kidney.de/pget.php?&tw=1&pmid=26330764 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26330764 #FOAvip English Wikipedia <ref>{{Cite pmid|26330764 }}</ref> Rituximab in refractory sarcoidosis: a single centre experience #MMPMID26330764 Cinetto F ; Compagno N ; Scarpa R ; Malipiero G ; Agostini C Clin Mol Allergy 2015[]; 13 (1 ): 19 PMID26330764 show ga Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease is still a great challenge. Rituximab is an anti-CD20 chimeric monoclonal antibody, currently used for the treatment of B cell malignancies and systemic autoimmune diseases. There are few case reports describing the successful use of Rituximab in refractory sarcoidosis with lung, eye, lymph nodes and skin involvement. In this paper we described three different case reports in which Rituximab has been used to treat refractory sarcoidosis and we reviewed the existing literature. äRituximab in refractory sarcoidosis: a single centre experience (epmc).pdf DeepDyve Pubget Overpricing